This was a brief introduction to the strategy. The fund is a multi-cap strategy with a third tending to be allocated to FTSE 100 companies, but it also invests in micro companies. Strong balance sheets are an important part of this strategy, and this has meant they have seen the strong get stronger as some of the competition has left the market.
They did see a reduction in dividends of around 26% compared to the market which was down 34%, but due to the nature of the companies that they invest in they have also seen dividends starting to come back.
The fund performed strongly post the vaccine announcements. However they still see some value within the fund, and they feel the market remains inefficient, meaning that it is a happy hunting ground for them. This means that they can find plenty of opportunities…..read more